Q32 Bio to Participate in Upcoming March Investor Conferences
Provided By PR Newswire
Last update: Feb 26, 2025
WALTHAM, Mass., Feb. 26, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced that management will participate in two upcoming investor conferences in March:
Read more at prnewswire.comNASDAQ:QTTB (10/21/2025, 10:11:09 AM)
3.2536
-0.08 (-2.29%)
Find more stocks in the Stock Screener
QTTB Latest News and Analysis
